Search research articles
Contact Us
Filters
Showing results (581-590 of 726) with videos related to
Page
of 73
Sort By:
Investigational New Drugs
|
January 1, 1994
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas
J E Romaguera, M A Rodriguez, F B Hagemeister, et al.
International Journal of Molecular Sciences
|
November 9, 2024
Conformational Plasticity Enhances the Brain Penetration of a Metabolically Stable, Dual-Functional Opioid-Peptide CycloAnt
Yangmei Li, William E Cotham, Abbe Eliasof, et al.
Leukemia & Lymphoma
|
June 1, 1995
Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase
S Suki, F Swan, S Tucker, et al.
Leukemia & Lymphoma
|
June 1, 1997
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma
A Younes, M A Rodriguez, P McLaughlin, et al.
Cancer
|
May 1, 1994
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis
W S Velasquez, P McLaughlin, L M Fuller, et al.
Irish Journal of Medical Science
|
January 25, 2022
Breast cancer recurrence: factors impacting occurrence and survival
Donald Courtney, Matthew G Davey, Brian M Moloney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1990
Small noncleaved cell lymphoma in adults: superior results for stages I-III disease
T M Lopez, F B Hagemeister, P McLaughlin, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 28, 2026
Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic Pain
Ryosuke Shinouchi, Bengisu Turgutalp, Rohini S Ople, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1999
Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids
W Xie, G M Samoriski, J P McLaughlin, et al.
AIDS (London, England)
|
February 1, 1997
Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England
R J MacGowan, R M Brackbill, D L Rugg, et al.
Page
of 73
Search research articles
Search
Showing results (581-590 of 726) with videos related to
Sort By:
Page
of 73
Investigational New Drugs
|
January 1, 1994
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas
J E Romaguera, M A Rodriguez, F B Hagemeister, et al.
International Journal of Molecular Sciences
|
November 9, 2024
Conformational Plasticity Enhances the Brain Penetration of a Metabolically Stable, Dual-Functional Opioid-Peptide CycloAnt
Yangmei Li, William E Cotham, Abbe Eliasof, et al.
Leukemia & Lymphoma
|
June 1, 1995
Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase
S Suki, F Swan, S Tucker, et al.
Leukemia & Lymphoma
|
June 1, 1997
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma
A Younes, M A Rodriguez, P McLaughlin, et al.
Cancer
|
May 1, 1994
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis
W S Velasquez, P McLaughlin, L M Fuller, et al.
Irish Journal of Medical Science
|
January 25, 2022
Breast cancer recurrence: factors impacting occurrence and survival
Donald Courtney, Matthew G Davey, Brian M Moloney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1990
Small noncleaved cell lymphoma in adults: superior results for stages I-III disease
T M Lopez, F B Hagemeister, P McLaughlin, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 28, 2026
Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic Pain
Ryosuke Shinouchi, Bengisu Turgutalp, Rohini S Ople, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1999
Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids
W Xie, G M Samoriski, J P McLaughlin, et al.
AIDS (London, England)
|
February 1, 1997
Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England
R J MacGowan, R M Brackbill, D L Rugg, et al.
Page
of 73